18 results
ARS
2024 FY
ABSI
Absci Corp
23 Apr 24
Annual report to shareholders
4:10pm
I. Item 1. Business Our Mission Absci is a data-first generative AI drug creation company that combines AI with scalable wet lab technologies … Capital Our employees, who we refer to as “Unlimiters”, are essential in our ability to serve our partners and achieve our mission to create better
8-K
EX-99.1
ABSI
Absci Corp
14 Aug 23
Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results
8:13am
toward our mission of creating better biologics for patients, faster."
Recent Highlights
Entered into partnership with a Google Ventures-backed
8-K
EX-99.1
ABSI
Absci Corp
6 Jun 23
Departure of Directors or Certain Officers
4:08pm
most about Absci's mission is the prospect of accelerating the development of breakthrough therapies, together with pharma and biotech companies
8-K
EX-99.1
ABSI
Absci Corp
15 May 23
Absci Reports Business Updates and First Quarter 2023 Financial and Operating Results
4:08pm
strategic portfolio across a range of therapeutic areas — and achieve our mission of creating better biologics for patients, faster."
Recent
ARS
phbnsw
28 Apr 23
Annual report to shareholders
12:00am
PRE 14A
qeu nspzrmv1
11 Apr 23
Preliminary proxy
5:49pm
8-K
EX-99.1
a9l6o420g9
2 Nov 22
Absci Welcomes Meta Senior Executive to Board of Directors
4:06pm
10-K
o03lugl iq
22 Mar 22
Annual report
5:20pm
424B4
v0qloiuyw
23 Jul 21
Prospectus supplement with pricing info
4:49pm
S-1/A
pq60ekti
8 Jul 21
IPO registration (amended)
5:04pm
S-1
99f3ih
30 Jun 21
IPO registration
3:20pm
DRS/A
s07g2vaitu8e6
16 Jun 21
Draft registration statement (amended)
12:00am
DRS
nrz7aositcw6zs 2x2
6 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next